Dentium (145720) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Dentium KRW 40,603, price KRW 36,600, upside +10.9%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Dentium for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products.
Show more
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Stock analysis
Dentium (145720) currently trades at 36,600 KRW, while our model-based Fair Value estimate is 40,603 KRW, implying the stock looks roughly 9.9% undervalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 43,696 KRW per share, and 9 of the 14 models we run sit above the 36,600 KRW price.
Bear case: the Earnings-Based group reads lowest at 18,002 KRW, and 5 of the 14 models stay below the price. Evidence for this calculation is medium.
Scenario range: 31,399 KRW (bear) to 42,738 KRW (bull), the price of 36,600 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Dentium reported revenue of 346B KRW in FY2025 versus 292B KRW in FY2021, a compound +4.4%/yr. Reported net income was 16.4B KRW in FY2025, compounding −26.3%/yr from FY2021.
Key figures
Market cap 316B KRW (≈ $232M) · P/S ratio 0.96 · Dividend yield 1.6% · Net margin 4.7% · Return on equity 3.6% · Return on assets (EBIT) 13.3% · Operating margin 22.2% · Revenue (TTM) 341B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 37% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at 11%, 145720 screens cheaper than that median.
Fair Value models
Bear 31,399 KRWFair Value 40,603 KRWBull 42,738 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−15.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
Start year 2020 (pandemic). Over 10 years: +13.8% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−4.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.2%
Dividend (yield on the price)1.6%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 19%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Dentium Fair Value". https://www.fairvalue-calculator.com/stock/145720
Frequently asked questions
Is Dentium (145720) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 40,603 KRW versus a price of 36,600 KRW, about +11% upside (undervalued).
What is the fair value of 145720?
Our model-based fair value for Dentium is 40,603 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 36,600 KRW.
What is the quality score of 145720?
Dentium has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Dentium (145720)?
Our model-based price target is the fair value of 40,603 KRW (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 31,399 KRW, optimistic scenario 42,738 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Dentium stock forecast for 2026?
Our models put fair value at 40,603 KRW, about +11% upside versus a price of 36,600 KRW (undervalued). Cautious scenario 31,399 KRW, optimistic scenario 42,738 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Dentium (145720)?
Dentium reported trailing-twelve-month revenue of about 341B KRW (latest available figure, as of Sep 24, 2026).
Does Dentium pay a dividend?
Dentium currently shows a dividend yield of about 1.64% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Dentium (145720)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Dentium it is 40,603 KRW per share (as of Sep 24, 2026), against a price of 36,600 KRW. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Dentium stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 145720 trades below its calculated fair value: price 36,600 KRW, fair value 40,603 KRW, a gap of about +11% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 145720?
No. The price is what the market pays today (36,600 KRW); the fair value is what the company's own numbers justify (40,603 KRW). For Dentium the two are 4,003 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Dentium worth?
The market values Dentium at about 316B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 36,600 KRW; our models calculate a fair value of 40,603 KRW per share.
What do the bullish and bearish scenarios say about 145720?
Our models span a range for Dentium: cautious scenario 31,399 KRW, base 40,603 KRW, optimistic 42,738 KRW per share (as of Sep 24, 2026, price 36,600 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Dentium (145720)?
Balance-sheet figures for Dentium (as of Sep 24, 2026): return on equity 3.6%, debt of 0.08 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is 145720 from its 52-week high?
Dentium trades at 36,600 KRW, about 37% below its 52-week high of 58,219 KRW and 1% above the low of 36,350 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 40,603 KRW is for.
Which stocks are comparable to Dentium?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Dentium stock attractive at the current price?
The data as of Sep 24, 2026: price 36,600 KRW, calculated fair value 40,603 KRW (+11%), Quality Score 40/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 145720 calculated?
We run Dentium through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 40,603 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Dentium currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Dentium (145720)?
The closing price on Sep 23, 2026 was 36,600 KRW. Our model-based fair value is 40,603 KRW, about +11% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Dentium right now?
The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Dentium
How large is the market capitalisation of Dentium (145720)?
The market capitalisation of Dentium is 316B KRW (≈ $232M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Dentium (145720)?
The price-to-sales ratio of Dentium is 0.96 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Dentium (145720)?
The dividend yield of Dentium is 1.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Dentium (145720)?
The net margin of Dentium is 4.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Dentium (145720)?
The return on equity (ROE) of Dentium is 3.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Dentium (145720)?
On an EBIT basis the return on assets of Dentium is 13.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Dentium (145720)?
The operating margin of Dentium is 22.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Dentium (145720)?
Revenue at Dentium is growing −7.1% versus a year earlier (3y avg −0.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Dentium (145720)?
Earnings per share at Dentium are growing +36.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Dentium (145720) generate?
The free cash flow of Dentium is −40.3B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Dentium (145720) carry?
The net debt of Dentium is 206B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Dentium in the live analysis
One click puts Dentium on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
